Editorial to the Postmarketing Surveillance on the Clinical Use of Edoxaban in Patients With Nonvalvular Atrial Fibrillation (ETNA-AF Japan): One-Year Safety and Effectiveness Analyses

Journal of Arrhythmia - Netherlands
doi 10.1002/joa3.12340
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan

Journal of Rheumatology
RheumatologyAllergyImmunology
2009English

Effectiveness and Safety of Tocilizumab: Postmarketing Surveillance of 7901 Patients With Rheumatoid Arthritis in Japan

Journal of Rheumatology
RheumatologyAllergyImmunology
2013English

Cost-Effectiveness of Therapies for Patients With Nonvalvular Atrial Fibrillation

Archives of Internal Medicine
1998English

Cost-Effectiveness Analysis of Apixaban Against Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation in Japan

Clinical Therapeutics
Pharmacology
2015English

Platelet Activation in Patients With Chronic Nonvalvular Atrial Fibrillation

International Heart Journal
MedicineCardiovascular MedicineCardiology
2006English

Noninvasive Surrogate Markers to Predict Thrombogenesis in Patients With Nonvalvular Atrial Fibrillation

Journal of Nihon University Medical Association
2016English

Potential of Machine Learning Methods to Identify Patients With Nonvalvular Atrial Fibrillation

Future Cardiology
Molecular MedicineCardiovascular MedicineCardiology
2020English

Cost-Effectiveness of Dabigatran (150 Mg Twice Daily) and Warfarin in Patients ≥65 Years With Nonvalvular Atrial Fibrillation

American Journal of Cardiology
Cardiovascular MedicineCardiology
2016English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy